Trial intelligence / Profile preview

Phase IV single-arm study of zanubrutinib in treatment-naive Waldenström macroglobulinemia in China

CTR20253625Phase 4Active

Sponsor

BeiGene

Start

Oct 2025

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1